Anthropic Launches Claude for Healthcare at JPM26
Anthropic has announced the launch of Claude for Healthcare, a version of its large language model suite configured for clinical providers and patients. The release was timed with the start of the 2026 J.P. Morgan Healthcare Conference in San Francisco, marking the company’s formal entry into regulated health environments.
Claude for Healthcare includes consumer-facing features that allow users to link health records, lab results, and fitness data from various apps. Users can ask Claude to summarize medical histories, interpret test results in accessible language, identify trends in health metrics, or prepare questions for clinical visits.
In the U.S., users on Claude Pro and Max plans can grant secure access to their health data. New HealthEx and Function connectors are available in beta, and Apple Health and Android Health Connect integrations are rolling out in beta this week via the Claude mobile apps.
Image credit: Anthropic
Claude for Healthcare builds on Anthropic’s existing Claude models, like Claude for Life Sciences, launched in October 2025, by adding tooling aimed at reducing administrative burden and supporting R&D processes. The platform now connects to core systems like CMS Coverage Database, ICD-10, NPI Registry, and PubMed to support tasks such as medical coding, claims management, and prior authorization.
A HIPAA-ready infrastructure allows enterprise deployments in compliance-heavy environments, and new Agent Skills for FHIR Development were introduced to improve health data interoperability.
Claude for Life Sciences is a version of Anthropic’s model suite configured for end-to-end scientific workflows, including discovery, bioinformatics, and regulatory tasks. It now also integrates with clinical trial and drug discovery platforms, including Medidata, ClinicalTrials.gov, bioRxiv, medRxiv, Open Targets, ChEMBL, and Owkin. The system is made to assist protocol drafting, data analysis, and literature review, with deployment across major cloud platforms.
The launch follows OpenAI’s recent release of ChatGPT Health and Healthcare. For detailed analysis on the adaptation of foundation models for biomedical applications and the growing role of neurosymbolic approaches, see our deep dives: New LLMs, Agents, and Graphs in Life Sciences and Can AI Diagnose Better Than Humans?.
Topic: Tech Giants
